Gsk Consumer Healthcare GSK has begun the sale of some of its consumer health brands, hoping to raise around £1 billion before spinning off its consumer healthcare business, according to reports In a report released today, Peter Welford from Jefferies maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price
Gsk Consumer Healthcare Updates Global Roster With Nine Agencies In British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles shot, met the main goal of a late-stage trial in adults over 50 years of BENSALEM, PA — Healthcare Services Group, Inc (NASDAQ: HCSG) has announced significant leadership changes, appointing Vikas Singh as Executive Vice President and Chief Financial Officer, effective The $13 billion acquisition of Change Healthcare strengthens GSK as a prime candidate for investment Diversified product portfolio across pharmaceuticals, vaccines and consumer health care British drugmaker GSK said on Wednesday its experimental herpes simplex virus (HSV) vaccine candidate failed to meet the main goal of a mid-stage trial and would not be taken forward to a late-stage
Comments are closed.